Serum cartonectin concentrations were significantly lower in patients with T2DM compared to controls [150.2 (72.9–288.7) vs. 248.9 (115.0–321.2) ng/ml; P<0.05: Table 1]. This evidence concerns the gene C1QTNF3 and type 2 diabetes mellitus.